Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ERI Group is a private U.S. medical technology services company focused on end-to-end medical product design, development, quality assurance, regulatory affairs, and contract manufacturing. Formerly known as Evergreen Research, the company rebranded to ERI Group in 2022 while emphasizing its engineering, regulatory, and innovation capabilities for healthcare, medical, laboratory, and consumer wellness products. ERI serves as an outsourced innovation and manufacturing partner for medical device companies, supporting programs from feasibility and verification/validation through clinical investigations, commercial production, and launch. The company appears primarily oriented toward complex electromechanical medical products rather than a therapeutic drug pipeline, and it operates manufacturing and design facilities in Colorado under ISO 13485 and ISO 9001 quality systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ERI Group.